WO2016171482A1 - Cosmetic composition including apitoxin extract, and method of manufacturing same - Google Patents

Cosmetic composition including apitoxin extract, and method of manufacturing same Download PDF

Info

Publication number
WO2016171482A1
WO2016171482A1 PCT/KR2016/004144 KR2016004144W WO2016171482A1 WO 2016171482 A1 WO2016171482 A1 WO 2016171482A1 KR 2016004144 W KR2016004144 W KR 2016004144W WO 2016171482 A1 WO2016171482 A1 WO 2016171482A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
cosmetic composition
weight
water
soluble
Prior art date
Application number
PCT/KR2016/004144
Other languages
French (fr)
Korean (ko)
Inventor
박진규
강은주
전종운
안창기
문정초
설성련
박규진
Original Assignee
농업회사법인 비센 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 농업회사법인 비센 주식회사 filed Critical 농업회사법인 비센 주식회사
Publication of WO2016171482A1 publication Critical patent/WO2016171482A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87Application Devices; Containers; Packaging

Definitions

  • the present invention relates to a cosmetic composition using bee venom and eochochocho extract, and more particularly, to a cosmetic composition exhibiting anti-aging effects such as wrinkle improvement by mixing fat soluble extract of bee venom and water soluble extract and echochocho extract and a method for producing the same. will be.
  • Bee Venom The venom that comes from the bee's spawning tube is called Bee Venom.
  • Bee venom is a natural animal bioactive substance stored in bee abdominal sac and linked to bee sting and secreted at the time of stimulation. It has been recorded that bee venom was used for therapeutic purposes in Egypt and Arabicia. In Korea, records of the use of raw acupuncture for the treatment of pain and rheumatoid arthritis have been recorded in the Demon King's white paper (the first acupuncture literature), consent and folk remedies.
  • This bee venom reduces edema in inflammatory animals, acts on synovial cells in patients with arthritis, and its main ingredient, melittin, inactivates NF- ⁇ B, reducing the amount of nitric oxide (NO) and cyclooxygena. It is known to induce anti-inflammatory effects by inhibiting Cyclooxygenase-2 (COX-2).
  • COX-2 Cyclooxygenase-2
  • Eoseongcho is a perennial herb belonging to more than three hundred, and its scientific name is Houttuynia. Cordata , and according to the Chinese Medicine Dictionary (Shanghai Science and Technology Publishing House), there are other names such as medicinal wheat and ten.
  • Echoseongcho removes boils and poisons along with antipyretic action
  • Chinese herbal medicine dictionary clears blood and removes inflammation
  • Eoseongcho contains active ingredients throughout the leaves, stems, and roots, and bioactive substances, including their unique odors, help metabolism to clear blood, promote kidney function, and excrete inflammatory symptoms and toxins in the body. Since ancient times, it has been widely used as a folk medicine in China and Japan.
  • Herbal herbs are used for hypertension, constipation, diabetes, fever, boil, detoxification, arthritis, inflammatory diseases, etc.
  • the main ingredients are decanoyl acetaldehyde, melon and myrsen, which are essential oils in the outpost.
  • Aldehydes have a titer of 40,000 times that of sulfamine antibiotics.
  • Korean Patent Application Publication No. 2014-0124172 and Korean Patent Registration No. 1383519 disclose that the content is applied as one component of a cosmetic composition.
  • the present inventors have disclosed a process for preparing bee venom extract using a fat-soluble solvent and a water-soluble solvent in Korean Patent No. 1425018, in the manufacturing process when separating the water-soluble solvent layer and the fat-soluble solvent layer to separate from each other In this case, the intermediate layer appears to be difficult to completely separate, which causes a problem of inconsistent yield.
  • the present inventors research and efforts to provide a cosmetic composition excellent in improving skin wrinkles and a method for producing a cosmetic composition that can ensure a constant yield, as a result, obtain bee venom extract according to filtration using a fat-soluble solvent and a water-soluble solvent,
  • the present invention was completed by discovering that a cosmetic composition excellent in improving skin wrinkles can be prepared according to collagen metabolism activation while securing a constant yield of fat-soluble extract and water-soluble extract.
  • an object of the present invention is to provide a cosmetic composition having excellent skin wrinkle improvement effect by activating collagen metabolism including bee venom extract and a method for producing the same.
  • the present invention is characterized in that the cosmetic composition comprising 50 to 500 parts by weight of Echochocho extract against 100 parts by weight of the bee venom extract mixed with the fat soluble extract of bee venom extracted by the fat-soluble solvent and the water soluble extract of bee venom extracted by the water-soluble solvent do.
  • the cosmetic composition of the present invention is characterized in that the fat-soluble extract and the water-soluble extract are mixed in a weight ratio of 1: 0.1-10.
  • the fat-soluble solvent is one or two or more mixed solvents selected from hexane, ether, glycerol, propylene glycol, butylene glycol, ethyl acetate, methyl acetate, dichloromethane and chloroform.
  • the water-soluble solvent is characterized in that one or two or more mixed solvents selected from water and C 1 ⁇ C 4 alcohol.
  • the Echoseongcho extract is characterized in that extracted with one or two or more mixed solvents selected from water and C 1 ⁇ C 4 alcohol.
  • the cosmetic composition of the present invention is 5 to 40% by weight melittin, 1 to 20% by weight of eicosenol, phospholipase A-2 1 to 20% by weight, 0.1 to 5% by weight of apamin (Apamin), It comprises 0.01 to 5% by weight of pinocembrin and 0.01 to 5% by weight of chrysin, characterized in that it comprises 1 to 10% by weight of quercitrin and 0.01 to 5% by weight of quercetin.
  • the present invention the bee venom in the fat-soluble solvent and filtered to obtain a fat-soluble extract of the filtrate;
  • the bee venom extract is characterized in that the fat-soluble extract and water-soluble extract is prepared by mixing in a weight ratio of 1: 0.1 to 10.
  • the present invention is another feature of a microneedle patch containing the cosmetic composition.
  • the cosmetic composition of the present invention promotes collagen synthesis and activates skin cell metabolism (ECM: Epidermal Cell Metabolism), thereby improving skin conditions including skin wrinkles.
  • ECM Epidermal Cell Metabolism
  • the cosmetic composition of the present invention can be used safely without cytotoxicity and skin side effects.
  • FIG. 1 is a schematic diagram showing a manufacturing process of the cosmetic composition according to an embodiment of the present invention.
  • FIG. 4 is a graph comparing collagen metabolic activity (Pro-collagen / MMP-1 ratio) of the cosmetic composition according to an embodiment of the present invention.
  • Figure 6 is a result of comparing the collagen synthesis effect and MMP-1 expression inhibitory effect according to the weight ratio of bee venom extract and Echochocho extract in the embodiment of the present invention.
  • FIG. 7 is a diagram illustrating a process of preparing a mixed solution for preparing a microneedle patch on which a cosmetic composition according to an embodiment of the present invention is mounted.
  • the present invention is characterized by a cosmetic composition
  • a cosmetic composition comprising a bee venom extract and Eochocho extract mixed with a fat soluble extract of bee venom extracted with a fat soluble solvent and a water soluble extract of bee venom extracted with a water soluble solvent.
  • Bee venom is a venom nectar from the bee spawning tube, and the bee venom used in the present invention may be live bee venom, dried bee venom or purified bee venom.
  • Raw bee venom is not dried or purified and has a specific gravity of 1.1 to 1.3, a pH in the range of 5.2 to 5.5, and contains 70 to 80% by weight of the peptide.
  • the cosmetic composition of the present invention contains 50 to 500 parts by weight of Echochocho extract, and preferably 80 to 400 parts by weight, more preferably 100 to 300 parts by weight, based on 100 parts by weight of the bee venom extract.
  • the bee venom extract is mixed with the fat soluble extract of bee venom extracted by the fat soluble solvent and the water soluble extract of bee venom extracted by the water soluble solvent, so that the fat soluble component and the water soluble component for skin wrinkle improvement are included in an optimal ratio.
  • the bee venom extract may be mixed with a fat-soluble extract and a water-soluble extract in a weight ratio of 1: 0.1 to 10, preferably 1: 1: 0.2 to 5.0, a weight ratio of more preferably 1: 0.5 to 2.0 It is more advantageous for the wrinkle improvement effect.
  • one or two or more mixed solvents selected from hexane, ether, glycerol, propylene glycol, butylene glycol, ethyl acetate, methyl acetate, dichloromethane and chloroform may be used, preferably ethyl acetate or Preference is given to using methyl acetate.
  • one or two or more kinds of mixed solvents selected from water and C 1 to C 4 alcohols may be used as the water-soluble solvent, and preferably water, methanol or ethanol is used.
  • Eochocho extract included in the cosmetic composition of the present invention Cordata
  • Cordata may be extracted using one or two or more mixed solvents selected from water and C 1 to C 4 alcohols, and preferably, extracts using water, methanol or ethanol.
  • the cosmetic composition of the present invention is 5 to 40% by weight melittin derived from bee venom extract, 1 to 20% by weight of eicosenol, phospholipase A-2 1 to 20% by weight, 0.1 to 5% by weight of apamin (Apamin) %, 0.01-5% by weight of pinocembrin and 0.01-5% by weight of chrysin, preferably 10-30% by weight of melittin, 5-15% by weight of eicosenol %, 5-15 wt% of phospholipase A-2, 0.5-3 wt% of Apamin, 0.01-3 wt% of pinocembrin, and 0.01-3 wt% of chrysin. Can be.
  • the cosmetic composition of the present invention may include 1 to 10% by weight of Quercitrin and 0.01 to 5% by weight of Quercetin derived from Eochocho extract, and preferably 2 to 8% by weight of Quercetin, Quercetin or
  • the derivatives may comprise 0.01 to 3% by weight.
  • Wrinkle development is known to be due to decreased collagen metabolism of the skin, collagen synthesis decreases due to oxidative stress or light damage, and increased degradation activity of Matrix metallo proteinase (MMP). Exposure of blasts to hydrogen peroxide stress decreased the amount of procollagen mRNA and protein and increased the amount of MMP-1 mRNA and protein due to oxidative stress.
  • the cosmetic composition of the present invention inhibits the MMP, promotes collagen synthesis, and ultimately activates skin cell metabolism (ECM: Epidermal Cell Metabolism) to improve skin conditions including skin wrinkles.
  • ECM Epidermal Cell Metabolism
  • pinocembrin and eicosenol in bee venom extract together with quercitrin and quercetin in Echo extract, promote collagen synthesis of skin cells and activate tyrosinase. It may have a whitening effect of inhibiting melanin production by participating in inhibition.
  • Quatcitrin is a bioflavonoid that has antioxidant properties and serves to inhibit skin damage and cell death by antibacterial and anti-inflammatory, anti-allergic, oxidation and UV rays.
  • the cosmetic composition of the present invention can ensure safety without cytotoxicity and skin side effects.
  • the present invention the bee venom in the fat-soluble solvent and filtered to obtain a fat-soluble extract of the filtrate; Putting the residue filtered by the filtration into a water-soluble solvent to obtain a water-soluble extract of the filtrate; Preparing a bee venom extract by mixing the fat-soluble extract and a water-soluble extract; And a method for preparing a cosmetic composition comprising mixing 50 to 500 parts by weight of Eochocho extract based on 100 parts by weight of the bee venom extract.
  • crude raw bee venom was added to one or two or more fat-soluble solvents selected from hexane, ether, glycerol, propylene glycol, butylene glycol, ethyl acetate, methyl acetate, dichloromethane and chloroform, and stirred and filtered. Get a fat-soluble extract. It is preferable to further proceed with the ultrasonication after the stirring.
  • the pore diameter when the filtration can be used to filter paper in the range of 0.1 ⁇ 10 ⁇ m, through which the fat-soluble extract and the residue of the filtrate is separated.
  • the filtered residue by filtration and put into one or two or more water-soluble solvent selected from water and C 1 ⁇ C 4 alcohol can be stirred and filtered to obtain a water-soluble extract of the filtrate. It is preferable to further proceed with the ultrasonication after the stirring.
  • the pore diameter during the filtration can be used to filter paper in the range 0.1 ⁇ 10 ⁇ m, through which the aqueous extract and insoluble matter of the filtrate is further separated.
  • the fat-soluble extract and the water-soluble extract are mixed in a weight ratio of 1: 0.1 to 10 to prepare bee venom extract.
  • the extract of Eoseongcho which is one component of the cosmetic composition of the present invention is prepared by extracting by a conventional method in the art, preferably one or two or more mixed solvents selected from water and C 1 to C 4 alcohols. It can be extracted by ultrasonication at room temperature. Next, 50 to 500 parts by weight, preferably 80 to 400 parts by weight, and more preferably 100 to 300 parts by weight of Eochocho extract, based on 100 parts by weight of the bee venom extract, to prepare a cosmetic composition.
  • the cosmetic composition comprises a cosmetically or dermatologically acceptable medium or base.
  • a cosmetically or dermatologically acceptable medium or base e.g. emulsions obtained by dispersing the oil phase in solutions, gels, solids, pasty anhydrous products, aqueous phases, emulsions obtained by dispersing the aqueous phase in oil phases, multiemulsions, suspensions, micro emulsions, micro
  • emulsions obtained by dispersing the aqueous phase in oil phases
  • multiemulsions obtained by dispersing the aqueous phase in oil phases
  • multiemulsions multiemulsions, suspensions, micro emulsions, micro
  • micro emulsions micro It may be provided in the form of an aerosol composition containing capsules, microgranulocytes, ionic (liposomal) and nonionic vesicle dispersants, foams or compressed propellants.
  • aerosol composition containing capsules, microgranulocytes, ionic (
  • Cosmetic compositions may include fatty substances, organic solvents, solubilizers, thickeners, gelling agents, emollients, antioxidants, suspending agents, stabilizers, foaming agents, fragrances, surfactants, water, ionic or nonionic emulsifiers, fillers , Metal ion sequestrants, chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or auxiliaries commonly used in the cosmetic or dermatological fields. have. Such adjuvants are introduced in amounts generally used in the cosmetic or dermatological fields.
  • the cosmetic composition is not particularly limited in the formulation, it is possible to appropriately select the formulation as desired.
  • the cosmetic composition may affect the dermal layer by penetrating the skin barrier through the microneedle patch.
  • the microneedles can be locally and continuously injected with active ingredients and can minimize pain when inserted into the skin.
  • the cosmetic composition may be mixed with a biodegradable polymer having excellent biocompatibility and mounted on a microneedle patch. When the mixed viscous solution is dried, the cosmetic composition may be in a solid state and may be re-dissolved by body fluid when injected into the body.
  • hyaluronic acid may be used, but is not limited thereto.
  • the active ingredient concentration in the cosmetic composition mounted on the microneedle patch may be 0.01 ⁇ 5.0 ⁇ g / ml, more preferably 0.1 ⁇ 3.0 ⁇ g / ml, most preferably 0.1 ⁇ 2.0 ⁇ g / ml.
  • the fat-soluble extract and the water-soluble extract were dried and mixed in a weight ratio of 1: 2 to prepare bee venom extract.
  • the bee venom extract and Eochocho extract were put in a solvent and mixed at a weight ratio of 1: 2 to obtain a cosmetic composition, and the results of component analysis of the cosmetic composition are shown in Table 1 below.
  • M3 shows the result of treatment of the bee venom extract of Example at a concentration of 0.083 ⁇ g / ml
  • M4 is a cosmetic product in which the bee venom extract and Echochocho extract of the example were mixed at concentrations of 0.083 ⁇ g / ml and 0.167 ⁇ g / ml, respectively. It is the result of processing a composition.
  • the Pro-collagen / MMP-1 ratio was calculated and shown in FIG. 4, and as shown in FIG. 4, the bee venom extract itself showed less than the result of the positive control Adenosine treatment (10 ⁇ M, 100 ⁇ M).
  • the cosmetic composition of the present invention showed an excellent value compared to the positive control group, it was confirmed that the collagen metabolism activity was significantly increased.
  • the composition of the present invention not only has a protective effect of regulating the metabolism of ECM when exposed to stress caused by UV-B irradiation, but also has an excellent rejuvenation effect that induces the synthesis of new collagen. .
  • EGCG (-)-Epigallocatechin-3-O, an anti-aging active ingredient of green tea, known as an anti-aging functional substance, EGF (Epidermal Growth Factor) and MMP-1 inhibitor, to compare the effects with other anti-aging ingredients -gallate].
  • the M4 composition of the present invention can be confirmed that the anti-aging effect is superior to EGF or EGCG.
  • composition was treated with different concentrations of bee venom extract and Echochocho extract as shown in Table 2, and the results are shown in FIG.
  • the microneedle patch was manufactured so that the composition of the present invention penetrates the skin barrier and affects the dermal layer.
  • the procedure is as follows.
  • viscous solution was prepared by mixing 1.92 g of hyaluronic acid, 3 mL of distilled water, and 0.2 mL of the M4 composition at 4 ° C. with 60% (w / v, dissolved in distilled water).
  • the viscous solution was dispensed in the form of droplets (droplet) of the mixed solution on one surface of the metal substrate, and dried at room temperature through air blowing while adjusting the length of the microneedle through the tensile process to prepare a microneedle patch.
  • the manufacturing process is shown in FIG.
  • the final length of the microneedle was set to about 300 ⁇ m to enable cosmetic use, and an average length of 332.79 ⁇ 27.80 ⁇ m and an average top diameter of 42.01 ⁇ 6.04 ⁇ m were prepared.
  • the microneedle-shaped patch was used as a gel foam patch (polyurethane film) attached, prepared in a size of 2 cm X 2 cm, 64 micro needles per patch were mounted at 1 mm intervals.
  • the microneedle was manufactured by adjusting the sum of concentrations of bee venom extract and Echochocho extract in the M4 composition to be 0.16, 0.25, 0.42, 0.50 ⁇ g / ml, and the same experiment as in Experimental Example 1 was conducted, and the results are illustrated in FIG. 8 is shown.
  • the concentration of the M4 composition inhibits MMP-1 expression in a concentration-dependent manner in the range of 0.25 ⁇ g / ml or more.

Abstract

The present invention relates to a cosmetic composition using apitoxin and Houttuynia cordata extracts and, more particularly, to a cosmetic composition having a fat soluble extract and a water soluble extract of an apitoxin and Houttuynia cordata extract mixed together so as to show anti-aging effects such as the alleviation of skin wrinkles, and to a method of manufacturing the cosmetic composition. The cosmetic composition of the present invention expedites collagen synthesis and activates the ECM (Epidermal Cell Metabolism) so as to show effects of skin condition improvement including the alleviation of skin wrinkles.

Description

봉독 추출물을 포함하는 화장료 조성물 및 이의 제조방법Cosmetic composition comprising bee venom extract and preparation method thereof
본 발명은 봉독 및 어성초 추출물을 이용한 화장료 조성물에 관한 것으로서, 더욱 상세하게는 봉독의 지용성 추출물과 수용성 추출물 및 어성초 추출물을 혼합하여 주름 개선과 같은 항노화 효과를 나타내는 화장료 조성물 및 이를 제조하는 방법에 관한 것이다. The present invention relates to a cosmetic composition using bee venom and eochochocho extract, and more particularly, to a cosmetic composition exhibiting anti-aging effects such as wrinkle improvement by mixing fat soluble extract of bee venom and water soluble extract and echochocho extract and a method for producing the same. will be.
본 출원은 2015년 4월 24일에 출원된 한국특허출원 제10-2015-0057894호에 기초한 우선권을 주장하며, 해당 출원의 명세서 및 도면에 개시된 모든 내용은 본 출원에 원용된다.This application claims priority based on Korean Patent Application No. 10-2015-0057894 filed on April 24, 2015, and all the contents disclosed in the specification and drawings of the application are incorporated in this application.
꿀벌의 산란관에서 나오는 독액을 봉독(Bee Venom)이라고 한다. 봉독은 벌 복부 끝 독낭에 저장되어 봉침과 연결되어 자극 시에 분비되는 동물성 천연 생리 활성물질로서 봉독이 이집트, 바빌로니아에서 치료 목적으로 사용되었다는 기록이 남아 있다. 우리나라에서도 마왕퇴백서(최초의 침구학 문헌), 동의보감, 민간요법에서 생봉침을 통증 및 류마티스 관절염 치료에 이용하였다는 기록이 남아 있다.The venom that comes from the bee's spawning tube is called Bee Venom. Bee venom is a natural animal bioactive substance stored in bee abdominal sac and linked to bee sting and secreted at the time of stimulation. It has been recorded that bee venom was used for therapeutic purposes in Egypt and Babylonia. In Korea, records of the use of raw acupuncture for the treatment of pain and rheumatoid arthritis have been recorded in the Demon King's white paper (the first acupuncture literature), consent and folk remedies.
이러한 봉독은 염증 유발 동물의 부종을 감소시키고, 관절염 환자의 활막세포에 작용하여 그 주성분 멜리틴(melittin)이 NF-ΚB를 비활성화시킴으로써 일산화질소(Nitric Oxide; NO)의 양을 감소시키며 싸이클로옥시게나아제-2(Cyclooxygenase-2; COX-2)를 억제하여 항염증 효과를 유발하는 것으로 알려져 있다. 봉독의 성분을 분리정제하여 치매나 암 치료에 이용하는 등의 봉독 처리 효과를 확인하는 생리적 연구나 건조 봉독의 성분 분석에 대한 연구 결과가 이미 보고되어 있다. 한의학에서는 염증 질환의 치료제로 오랫동안 사용되어 왔으며, 봉독의 항염증 효과와 항암효과에 대하여 연구하고 있다. This bee venom reduces edema in inflammatory animals, acts on synovial cells in patients with arthritis, and its main ingredient, melittin, inactivates NF-ΚB, reducing the amount of nitric oxide (NO) and cyclooxygena. It is known to induce anti-inflammatory effects by inhibiting Cyclooxygenase-2 (COX-2). There have been reports of physiological studies confirming the effects of bee venom treatment by separately purifying the components of bee venom and treating them with dementia or cancer. In oriental medicine, it has been used for the treatment of inflammatory diseases for a long time and studies the anti-inflammatory and anticancer effects of bee venom.
한편, 어성초는 삼백초과에 속하는 다년생 초본으로서 학명은 Houttuynia Cordata이고, 중약대사전(상해과학기술출판사)에 따르면 약모밀, 십약 등의 다른 이름이 있다.Meanwhile, Eoseongcho is a perennial herb belonging to more than three hundred, and its scientific name is Houttuynia. Cordata , and according to the Chinese Medicine Dictionary (Shanghai Science and Technology Publishing House), there are other names such as medicinal wheat and ten.
본초강목(本草綱目)에는 어성초가 해열작용과 함께 종기, 독 등을 없앤다고 기술되어 있으며, 중약대사전(重藥大辭典)에는 피를 맑게 해주고 염증을 없애준다고 기록되어 있다. It is described that Echoseongcho removes boils and poisons along with antipyretic action, and Chinese herbal medicine dictionary clears blood and removes inflammation.
어성초는 잎, 줄기, 뿌리 전체에 유효성분이 함유되어 있으며 특유의 독특한 냄새를 포함한 생리활성물질들이 신진대사를 도와 혈액을 맑게 하고 신장기능을 촉진시키며, 염증 증상과 체내 독소를 배설하는 등의 기능이 있어, 옛날부터 중국, 일본 등에서 민간약으로 널리 이용되어 왔다.Eoseongcho contains active ingredients throughout the leaves, stems, and roots, and bioactive substances, including their unique odors, help metabolism to clear blood, promote kidney function, and excrete inflammatory symptoms and toxins in the body. Since ancient times, it has been widely used as a folk medicine in China and Japan.
한방에서 어성초는 고혈압, 변비증, 당뇨병, 해열, 종기, 해독, 관절염, 염증성 질환 등에 이용되고 있으며, 주요성분으로는 전초에 정유성분인 데카노일아세트알데히드, 메론, 미르센 등이 있는데 이중 데카노일아세트알데히드는 설파민 항생제의 40,000배의 역가를 지니고 있다. 또한, 어성초 추물물과 관련하여서 한국공개특허 제2014-0124172호, 한국등록특허 제1383519호에서는 화장료 조성물의 일 구성 성분으로 적용하는 내용이 개시된 바 있다. Herbal herbs are used for hypertension, constipation, diabetes, fever, boil, detoxification, arthritis, inflammatory diseases, etc. The main ingredients are decanoyl acetaldehyde, melon and myrsen, which are essential oils in the outpost. Aldehydes have a titer of 40,000 times that of sulfamine antibiotics. In addition, in relation to Eoseongcho extract, Korean Patent Application Publication No. 2014-0124172 and Korean Patent Registration No. 1383519 disclose that the content is applied as one component of a cosmetic composition.
한편, 본 발명자들은 한국등록특허 제1425018호에서 지용성 용매와 수용성 용매를 사용하여 봉독 추출물을 제조하는 과정을 개시한 바 있으나, 상기 제조 과정에서는 수용성 용매층과 지용성 용매층을 서로 분획하여 분리할 때, 중간층이 나타나 완벽한 분리가 어려워지며, 이로 인하여 수율이 일정하지 않은 문제가 있었다. On the other hand, the present inventors have disclosed a process for preparing bee venom extract using a fat-soluble solvent and a water-soluble solvent in Korean Patent No. 1425018, in the manufacturing process when separating the water-soluble solvent layer and the fat-soluble solvent layer to separate from each other In this case, the intermediate layer appears to be difficult to completely separate, which causes a problem of inconsistent yield.
따라서 봉독 추출물을 활용한 화장료 조성물의 제조 방법에 대한 개발이 지속적으로 요구되고 있는 실정이다. Therefore, the situation for the development of a method for producing a cosmetic composition using bee venom extract is constantly required.
이에 본 발명자들은 피부 주름 개선 효과가 우수한 화장료 조성물 및 수율을 일정하게 확보할 수 있는 화장료 조성물의 제조 방법을 제공하고자 연구, 노력한 결과, 지용성 용매 및 수용성 용매 각각을 사용한 여과에 따라 봉독 추출물을 얻고, 이를 어성초 추출물과 일정 비율로 혼합하면 지용성 추출물과 수용성 추출물의 수율을 일정하게 확보하면서도 콜라겐 대사 활성화에 따라 피부 주름 개선 효과가 우수한 화장료 조성물을 제조할 수 있음을 발견함으로써 본 발명을 완성하게 되었다. Accordingly, the present inventors research and efforts to provide a cosmetic composition excellent in improving skin wrinkles and a method for producing a cosmetic composition that can ensure a constant yield, as a result, obtain bee venom extract according to filtration using a fat-soluble solvent and a water-soluble solvent, When the mixture with Eochocho extract in a certain ratio, the present invention was completed by discovering that a cosmetic composition excellent in improving skin wrinkles can be prepared according to collagen metabolism activation while securing a constant yield of fat-soluble extract and water-soluble extract.
따라서 본 발명은 봉독 추출물을 포함하여 콜라겐 대사 활성화에 의한 피부 주름 개선 효과가 우수한 화장료 조성물 및 이의 제조방법을 제공하는 것을 그 목적으로 한다. Therefore, an object of the present invention is to provide a cosmetic composition having excellent skin wrinkle improvement effect by activating collagen metabolism including bee venom extract and a method for producing the same.
본 발명은, 지용성 용매에 의하여 추출된 봉독의 지용성 추출물과 수용성 용매에 의하여 추출된 봉독의 수용성 추출물이 혼합된 봉독 추출물 100 중량부에 대하여 어성초 추출물 50 내지 500 중량부가 포함되는 화장료 조성물을 그 특징으로 한다. The present invention is characterized in that the cosmetic composition comprising 50 to 500 parts by weight of Echochocho extract against 100 parts by weight of the bee venom extract mixed with the fat soluble extract of bee venom extracted by the fat-soluble solvent and the water soluble extract of bee venom extracted by the water-soluble solvent do.
본 발명의 화장료 조성물은 상기 지용성 추출물과 수용성 추출물이 1 : 0.1 ~ 10 의 중량비로 혼합되는 것을 특징으로 한다. The cosmetic composition of the present invention is characterized in that the fat-soluble extract and the water-soluble extract are mixed in a weight ratio of 1: 0.1-10.
또한, 본 발명의 화장료 조성물에 있어서, 상기 지용성 용매는 헥산, 에테르, 글리세롤, 프로필렌글리콜, 부틸렌글리콜, 에틸아세테이트, 메틸아세테이트, 디클로로메탄 및 클로로포름 중에서 선택되는 1종 또는 2종 이상의 혼합 용매인 것을 특징으로 하고, 상기 수용성 용매는 물 및 C1 ~ C4의 알코올 중에서 선택되는 1종 또는 2종 이상의 혼합 용매인 것을 특징으로 한다. In addition, in the cosmetic composition of the present invention, the fat-soluble solvent is one or two or more mixed solvents selected from hexane, ether, glycerol, propylene glycol, butylene glycol, ethyl acetate, methyl acetate, dichloromethane and chloroform. The water-soluble solvent is characterized in that one or two or more mixed solvents selected from water and C 1 ~ C 4 alcohol.
또한, 본 발명의 화장료 조성물에 있어서, 상기 어성초 추출물은 물 및 C1 ~ C4의 알코올 중에서 선택되는 1종 또는 2종 이상의 혼합 용매에 의하여 추출된 것을 특징으로 한다. In addition, in the cosmetic composition of the present invention, the Echoseongcho extract is characterized in that extracted with one or two or more mixed solvents selected from water and C 1 ~ C 4 alcohol.
또한, 본 발명의 화장료 조성물은 멜리틴 5 ~ 40 중량%, 에이코세놀(eicosenol) 1 ~ 20 중량%, 포스포리파제A-2 1 ~ 20 중량%, 아파민(Apamin) 0.1 ~ 5 중량%, 피노셈브린(pinocembrin) 0.01 ~ 5 중량% 및 크리신(chrysin) 0.01 ~ 5 중량%를 포함하고, 쿼시트린 1 ~ 10 중량% 및 쿼세틴 0.01 ~ 5 중량%를 포함하는 것을 특징으로 한다. In addition, the cosmetic composition of the present invention is 5 to 40% by weight melittin, 1 to 20% by weight of eicosenol, phospholipase A-2 1 to 20% by weight, 0.1 to 5% by weight of apamin (Apamin), It comprises 0.01 to 5% by weight of pinocembrin and 0.01 to 5% by weight of chrysin, characterized in that it comprises 1 to 10% by weight of quercitrin and 0.01 to 5% by weight of quercetin.
한편, 본 발명은, 봉독을 지용성 용매에 넣고 여과하여 여액의 지용성 추출물을 얻는 단계; On the other hand, the present invention, the bee venom in the fat-soluble solvent and filtered to obtain a fat-soluble extract of the filtrate;
상기 여과에 의하여 걸러진 잔사를 수용성 용매에 넣고 여과하여 여액의 수용성 추출물을 얻는 단계; Putting the residue filtered by the filtration into a water-soluble solvent to obtain a water-soluble extract of the filtrate;
상기 지용성 추출물과 수용성 추출물을 혼합하여 봉독 추출물을 제조하는 단계; 및 Preparing a bee venom extract by mixing the fat-soluble extract and a water-soluble extract; And
상기 봉독 추출물 100 중량부에 대하여 어성초 추출물 50 내지 500 중량부를 혼합하는 단계를 포함하는 화장료 조성물의 제조 방법을 또 다른 특징으로 한다. It characterized by another method for producing a cosmetic composition comprising the step of mixing 50 to 500 parts by weight of Eochocho extract based on 100 parts by weight of the bee venom extract.
상기 화장료 조성물의 제조 방법에 있어서, 상기 봉독 추출물은 지용성 추출물과 수용성 추출물을 1 : 0.1 ~ 10 의 중량비로 혼합하여 제조되는 것을 특징으로 한다.In the manufacturing method of the cosmetic composition, the bee venom extract is characterized in that the fat-soluble extract and water-soluble extract is prepared by mixing in a weight ratio of 1: 0.1 to 10.
한편, 본 발명은 상기 화장료 조성물을 포함하는 마이크로 니들 패취를 또 다른 특징으로 한다. On the other hand, the present invention is another feature of a microneedle patch containing the cosmetic composition.
본 발명의 화장료 조성물은 콜라겐 합성을 촉진하고, 피부 세포의 대사(ECM: Epidermal Cell Metabolism)를 활성화하여 피부 주름을 비롯한 피부 상태의 개선 효과를 나타낸다. The cosmetic composition of the present invention promotes collagen synthesis and activates skin cell metabolism (ECM: Epidermal Cell Metabolism), thereby improving skin conditions including skin wrinkles.
또한, 본 발명의 화장료 조성물은 세포 독성 및 피부 부작용도 없어 안전하게 사용될 수 있다. In addition, the cosmetic composition of the present invention can be used safely without cytotoxicity and skin side effects.
도 1은 본 발명의 일실시예에 따른 화장료 조성물의 제조 과정을 나타낸 모식도이다. 1 is a schematic diagram showing a manufacturing process of the cosmetic composition according to an embodiment of the present invention.
도 2는 본 발명의 실시예에 따른 화장료 조성물의 프로콜라겐 합성 효과 및 MMP-1 발현 억제 효과를 확인한 결과이다. 2 is a result confirming the procollagen synthesis effect and MMP-1 expression inhibitory effect of the cosmetic composition according to an embodiment of the present invention.
도 3는 본 발명의 실시예에 따른 화장료 조성물과 Adenosine의 비교 실험을 진행한 결과이다. 3 is a result of the comparative experiment of the cosmetic composition and Adenosine according to an embodiment of the present invention.
도 4는 본 발명의 실시예에 따른 화장료 조성물의 콜라겐 대사활성(Pro-collagen/MMP-1 ratio)을 비교한 그래프이다. 4 is a graph comparing collagen metabolic activity (Pro-collagen / MMP-1 ratio) of the cosmetic composition according to an embodiment of the present invention.
도 5는 본 발명의 실시예에 따른 화장료 조성물과 EGF(Epidermal Growth Factor) 및 EGCG [(-)-Epigallocatechin-3-O-gallate]의 비교 실험을 진행한 결과이다. 5 is a result of a comparative experiment of the cosmetic composition according to an embodiment of the present invention and EGF (Epidermal Growth Factor) and EGCG [(-)-Epigallocatechin-3-O-gallate].
도 6은 본 발명의 실시예에서 봉독 추출물과 어성초 추출물의 중량비에 따른 프로콜라겐 합성 효과 및 MMP-1 발현 억제 효과를 비교한 결과이다. Figure 6 is a result of comparing the collagen synthesis effect and MMP-1 expression inhibitory effect according to the weight ratio of bee venom extract and Echochocho extract in the embodiment of the present invention.
도 7은 본 발명의 실시예에 따른 화장료 조성물을 탑재한 마이크로 니들 패취를 제조하기 위한 혼합 용액의 제조 과정을 도식화한 것이다. 7 is a diagram illustrating a process of preparing a mixed solution for preparing a microneedle patch on which a cosmetic composition according to an embodiment of the present invention is mounted.
도 8은 본 발명의 실시예에 따른 화장료 조성물을 탑재한 마이크로 니들 패취의 적용 시 조성물의 유효 농도 범위를 확인하기 위한 실험 결과이다. 8 is an experimental result for confirming the effective concentration range of the composition when applying the microneedle patch with a cosmetic composition according to an embodiment of the present invention.
본 발명은 지용성 용매에 의하여 추출된 봉독의 지용성 추출물과 수용성 용매에 의하여 추출된 봉독의 수용성 추출물이 혼합된 봉독 추출물과 어성초 추출물을 포함하는 화장료 조성물을 그 특징으로 한다. The present invention is characterized by a cosmetic composition comprising a bee venom extract and Eochocho extract mixed with a fat soluble extract of bee venom extracted with a fat soluble solvent and a water soluble extract of bee venom extracted with a water soluble solvent.
봉독은 꿀벌의 산란관에서 나오는 독액으로서, 본 발명에서 사용되는 봉독은 생봉독, 건조봉독, 정제봉독일 수 있다. 생봉독은 건조 또는 정제과정을 거치지 않은 것으로서 일반적으로 비중이 1.1 ~ 1.3이고, pH가 5.2 내지 5.5 범위이며, 70 ~ 80중량%의 펩타이드를 포함한다. Bee venom is a venom nectar from the bee spawning tube, and the bee venom used in the present invention may be live bee venom, dried bee venom or purified bee venom. Raw bee venom is not dried or purified and has a specific gravity of 1.1 to 1.3, a pH in the range of 5.2 to 5.5, and contains 70 to 80% by weight of the peptide.
본 발명의 화장료 조성물은 상기 봉독 추출물 100 중량부에 대하여 어성초 추출물 50 내지 500 중량부가 포함되고, 바람직하게는 80 내지 400 중량부, 더욱 바람직하게는 100 내지 300 중량부가 포함되는 것이 좋다. The cosmetic composition of the present invention contains 50 to 500 parts by weight of Echochocho extract, and preferably 80 to 400 parts by weight, more preferably 100 to 300 parts by weight, based on 100 parts by weight of the bee venom extract.
본 발명의 화장료 조성물에서 봉독 추출물은 지용성 용매에 의하여 추출된 봉독의 지용성 추출물과 수용성 용매에 의하여 추출된 봉독의 수용성 추출물이 혼합되어 피부 주름 개선을 위한 지용성 성분과 수용성 성분이 최적 비율로 포함된다. In the cosmetic composition of the present invention, the bee venom extract is mixed with the fat soluble extract of bee venom extracted by the fat soluble solvent and the water soluble extract of bee venom extracted by the water soluble solvent, so that the fat soluble component and the water soluble component for skin wrinkle improvement are included in an optimal ratio.
상기 봉독 추출물은 지용성 추출물과 수용성 추출물이 1 : 0.1 ~ 10 의 중량비로 혼합될 수 있으며, 바람직하게는 1 : 0.2 ~ 5.0 의 중량비, 더욱 바람직하게는 1 : 0.5 ~ 2.0 의 중량비로 혼합되는 것이 피부 주름 개선 효과에 보다 유리하다. The bee venom extract may be mixed with a fat-soluble extract and a water-soluble extract in a weight ratio of 1: 0.1 to 10, preferably 1: 1: 0.2 to 5.0, a weight ratio of more preferably 1: 0.5 to 2.0 It is more advantageous for the wrinkle improvement effect.
상기 지용성 용매로는 헥산, 에테르, 글리세롤, 프로필렌글리콜, 부틸렌글리콜, 에틸아세테이트, 메틸아세테이트, 디클로로메탄 및 클로로포름 중에서 선택되는 1종 또는 2종 이상의 혼합 용매가 사용될 수 있으며, 바람직하게는 에틸아세테이트 또는 메틸아세테이트를 사용하는 것이 바람직하다. As the fat-soluble solvent, one or two or more mixed solvents selected from hexane, ether, glycerol, propylene glycol, butylene glycol, ethyl acetate, methyl acetate, dichloromethane and chloroform may be used, preferably ethyl acetate or Preference is given to using methyl acetate.
또한, 상기 수용성 용매로는 물 및 C1 ~ C4의 알코올 중에서 선택되는 1종 또는 2종 이상의 혼합 용매가 사용될 수 있으며, 바람직하게는 물, 메탄올 또는 에탄올을 사용하는 것이 바람직하다. In addition, one or two or more kinds of mixed solvents selected from water and C 1 to C 4 alcohols may be used as the water-soluble solvent, and preferably water, methanol or ethanol is used.
한편, 본 발명의 화장료 조성물에 포함되는 어성초 추출물(Houttuynia Cordata)은 물 및 C1 ~ C4의 알코올 중에서 선택되는 1종 또는 2종 이상의 혼합 용매를 사용하여 추출한 것일 수 있으며, 바람직하게는 물, 메탄올 또는 에탄올을 사용한 추출물이 포함될 수 있다. On the other hand, Eochocho extract ( Houtuynia) included in the cosmetic composition of the present invention Cordata ) may be extracted using one or two or more mixed solvents selected from water and C 1 to C 4 alcohols, and preferably, extracts using water, methanol or ethanol.
본 발명의 화장료 조성물은 봉독 추출물 유래의 멜리틴 5 ~ 40 중량%, 에이코세놀(eicosenol) 1 ~ 20 중량%, 포스포리파제A-2 1 ~ 20 중량%, 아파민(Apamin) 0.1 ~ 5 중량%, 피노셈브린(pinocembrin) 0.01 ~ 5 중량% 및 크리신(chrysin) 0.01 ~ 5 중량%을 포함할 수 있으며, 바람직하게는 멜리틴 10 ~ 30 중량%, 에이코세놀(eicosenol) 5 ~ 15 중량%, 포스포리파제A-2 5 ~ 15 중량%, 아파민(Apamin) 0.5 ~ 3 중량%, 피노셈브린(pinocembrin) 0.01 ~ 3 중량% 및 크리신(chrysin) 0.01 ~ 3 중량%을 포함할 수 있다. The cosmetic composition of the present invention is 5 to 40% by weight melittin derived from bee venom extract, 1 to 20% by weight of eicosenol, phospholipase A-2 1 to 20% by weight, 0.1 to 5% by weight of apamin (Apamin) %, 0.01-5% by weight of pinocembrin and 0.01-5% by weight of chrysin, preferably 10-30% by weight of melittin, 5-15% by weight of eicosenol %, 5-15 wt% of phospholipase A-2, 0.5-3 wt% of Apamin, 0.01-3 wt% of pinocembrin, and 0.01-3 wt% of chrysin. Can be.
또한 본 발명의 화장료 조성물은 어성초 추출물 유래의 쿼시트린(Quercitrin) 1 ~ 10 중량% 및 쿼세틴(Quercetin) 0.01 ~ 5 중량%를 포함할 수 있으며, 바람직하게는 쿼시트린 2 ~ 8 중량%, 쿼세틴 또는 그 유도체들(Quercetin-glucose, Quercetin-galactose) 0.01 ~ 3 중량%를 포함할 수 있다. In addition, the cosmetic composition of the present invention may include 1 to 10% by weight of Quercitrin and 0.01 to 5% by weight of Quercetin derived from Eochocho extract, and preferably 2 to 8% by weight of Quercetin, Quercetin or The derivatives (Quercetin-glucose, Quercetin-galactose) may comprise 0.01 to 3% by weight.
주름 발생은 피부의 콜라겐(collagen) 대사능력이 감소하고, 산화스트레스나 광 손상에 의하여 콜라겐의 합성능이 감소하며 Matrix metallo proteinase(MMP)의 분해활성이 증가하기 때문으로 알려져 있으며, 사람 유래의 진피 섬유아세포를 과산화수소 스트레스에 노출시키면 프로콜라겐(Pro-collagen)의 mRNA와 단백질의 양이 감소하고, MMP-1의 mRNA와 단백질의 양이 산화스트레스에 의해 증가하는 것이 확인된다. 본 발명의 화장료 조성물은 상기 MMP를 억제하여 콜라겐 합성을 촉진하고, 궁극적으로 피부 세포의 대사(ECM: Epidermal Cell Metabolism)를 활성화하여 피부 주름을 비롯한 피부 상태의 개선 효과를 보인다, Wrinkle development is known to be due to decreased collagen metabolism of the skin, collagen synthesis decreases due to oxidative stress or light damage, and increased degradation activity of Matrix metallo proteinase (MMP). Exposure of blasts to hydrogen peroxide stress decreased the amount of procollagen mRNA and protein and increased the amount of MMP-1 mRNA and protein due to oxidative stress. The cosmetic composition of the present invention inhibits the MMP, promotes collagen synthesis, and ultimately activates skin cell metabolism (ECM: Epidermal Cell Metabolism) to improve skin conditions including skin wrinkles.
또한, 봉독 추출물 내 피노셈브린(pinocembrin) 및 에이코세놀(eicosenol)은 어성초 추출물 내 쿼시트린(Quercitrin) 및 쿼세틴(Quercetin)과 함께 피부 세포의 콜라겐 합성을 촉진하고 타이로시네이즈(tyrosinase)의 활성 억제에 관여하여 멜라닌 생성을 억제하는 미백 효과를 가질 수 있다. 쿼시트린은 항산화 성질을 갖는 바이오플라보노이드로서 항박테리아 및 항염, 항알러지, 산화 및 UV에 의한 피부손상과 세포사 등을 억제하는 역할을 한다.In addition, pinocembrin and eicosenol in bee venom extract, together with quercitrin and quercetin in Echo extract, promote collagen synthesis of skin cells and activate tyrosinase. It may have a whitening effect of inhibiting melanin production by participating in inhibition. Quatcitrin is a bioflavonoid that has antioxidant properties and serves to inhibit skin damage and cell death by antibacterial and anti-inflammatory, anti-allergic, oxidation and UV rays.
그리고 본 발명의 화장료 조성물은 세포 독성 및 피부 부작용도 없어 안전성을 확보할 수 있다. And the cosmetic composition of the present invention can ensure safety without cytotoxicity and skin side effects.
한편, 본 발명은, 봉독을 지용성 용매에 넣고 여과하여 여액의 지용성 추출물을 얻는 단계; 상기 여과에 의하여 걸러진 잔사를 수용성 용매에 넣고 여과하여 여액의 수용성 추출물을 얻는 단계; 상기 지용성 추출물과 수용성 추출물을 혼합하여 봉독 추출물을 제조하는 단계; 및 상기 봉독 추출물 100 중량부에 대하여 어성초 추출물 50 내지 500 중량부를 혼합하는 단계를 포함하는 화장료 조성물의 제조 방법을 또 다른 특징으로 한다. On the other hand, the present invention, the bee venom in the fat-soluble solvent and filtered to obtain a fat-soluble extract of the filtrate; Putting the residue filtered by the filtration into a water-soluble solvent to obtain a water-soluble extract of the filtrate; Preparing a bee venom extract by mixing the fat-soluble extract and a water-soluble extract; And a method for preparing a cosmetic composition comprising mixing 50 to 500 parts by weight of Eochocho extract based on 100 parts by weight of the bee venom extract.
보다 구체적으로 미정제된 생봉독을 헥산, 에테르, 글리세롤, 프로필렌글리콜, 부틸렌글리콜, 에틸아세테이트, 메틸아세테이트, 디클로로메탄 및 클로로포름 중에서 선택되는 1종 또는 2종 이상의 지용성 용매에 넣고 교반하고 여과하여 여액의 지용성 추출물을 얻는다. 상기 교반 후 초음파 처리를 추가적으로 진행하는 것이 바람직하다. 또한, 상기 여과 시 포어 지름은 0.1 ~ 10 μm 범위의 거름종이를 사용할 수 있으며, 이를 통하여 여액의 지용성 추출물과 잔사를 분리한다. More specifically, crude raw bee venom was added to one or two or more fat-soluble solvents selected from hexane, ether, glycerol, propylene glycol, butylene glycol, ethyl acetate, methyl acetate, dichloromethane and chloroform, and stirred and filtered. Get a fat-soluble extract. It is preferable to further proceed with the ultrasonication after the stirring. In addition, the pore diameter when the filtration can be used to filter paper in the range of 0.1 ~ 10 μm, through which the fat-soluble extract and the residue of the filtrate is separated.
상기 여과에 의하여 걸러진 잔사를 건조시킨 후 물 및 C1 ~ C4의 알코올 중에서 선택되는 1종 또는 2종 이상의 수용성 용매에 넣고 교반하고 여과하여 여액의 수용성 추출물을 얻을 수 있다. 상기 교반 후 초음파 처리를 추가적으로 진행하는 것이 바람직하다. 또한, 상기 여과 시 포어 지름은 0.1 ~ 10 μm 범위의 거름종이를 사용할 수 있으며, 이를 통하여 여액의 수용성 추출물과 불용물을 추가적으로 분리한다. After drying the filtered residue by filtration and put into one or two or more water-soluble solvent selected from water and C 1 ~ C 4 alcohol can be stirred and filtered to obtain a water-soluble extract of the filtrate. It is preferable to further proceed with the ultrasonication after the stirring. In addition, the pore diameter during the filtration can be used to filter paper in the range 0.1 ~ 10 μm, through which the aqueous extract and insoluble matter of the filtrate is further separated.
상기 지용성 추출물과 수용성 추출물을 각각 건조한 후, 지용성 추출물과 수용성 추출물을 1 : 0.1 ~ 10 의 중량비로 혼합하여 봉독 추출물을 제조한다. After drying the fat-soluble extract and the water-soluble extract, respectively, the fat-soluble extract and the water-soluble extract are mixed in a weight ratio of 1: 0.1 to 10 to prepare bee venom extract.
또한, 본 발명의 화장료 조성물의 일 성분인 어성초 추출물을 당해 기술분야의 통상적인 방법으로 추출하여 제조하되, 바람직하게는 물 및 C1 ~ C4의 알코올 중에서 선택되는 1종 또는 2종 이상의 혼합 용매에 넣고 상온에서 초음파 처리하여 추출할 수 있다. 다음 상기 봉독 추출물 100 중량부에 대하여 어성초 추출물 50 내지 500 중량부, 바람직하게는 80 내지 400 중량부, 더욱 바람직하게는 100 내지 300 중량부를 혼합하여 화장료 조성물을 제조한다.In addition, the extract of Eoseongcho which is one component of the cosmetic composition of the present invention is prepared by extracting by a conventional method in the art, preferably one or two or more mixed solvents selected from water and C 1 to C 4 alcohols. It can be extracted by ultrasonication at room temperature. Next, 50 to 500 parts by weight, preferably 80 to 400 parts by weight, and more preferably 100 to 300 parts by weight of Eochocho extract, based on 100 parts by weight of the bee venom extract, to prepare a cosmetic composition.
상기 화장료 조성물은 화장품학 또는 피부과학적으로 허용 가능한 매질 또는 기제를 포함한다. 이는 국소 적용에 적합한 모든 제형으로, 예를 들면, 용액, 겔, 고체, 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 유상에 수상을 분산시켜 얻은 에멀젼, 멀티에멀젼, 현탁액, 마이크로 에멀젼, 마이크로캡슐, 미세 과립구, 이온형(리포좀) 및 비이온형의 소낭 분산제, 포말(foam) 또는 압축된 추진제를 함유한 에어로졸 조성물의 형태로 제공될 수 있다. 이들 조성물은 당해 분야의 통상적인 방법에 따라 제조될 수 있다.The cosmetic composition comprises a cosmetically or dermatologically acceptable medium or base. These are all formulations suitable for topical application, e.g. emulsions obtained by dispersing the oil phase in solutions, gels, solids, pasty anhydrous products, aqueous phases, emulsions obtained by dispersing the aqueous phase in oil phases, multiemulsions, suspensions, micro emulsions, micro It may be provided in the form of an aerosol composition containing capsules, microgranulocytes, ionic (liposomal) and nonionic vesicle dispersants, foams or compressed propellants. These compositions can be prepared according to conventional methods in the art.
화장료 조성물은 지방 물질, 유기 용매, 용해제, 농축제, 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면 활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제, 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품학 또는 피부과학 분야에서 통상적으로 사용되는 보조제를 더 포함할 수 있다. 상기 보조제는 화장품학 또는 피부 과학 분야에서 일반적으로 사용되는 양으로 도입된다.Cosmetic compositions may include fatty substances, organic solvents, solubilizers, thickeners, gelling agents, emollients, antioxidants, suspending agents, stabilizers, foaming agents, fragrances, surfactants, water, ionic or nonionic emulsifiers, fillers , Metal ion sequestrants, chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or auxiliaries commonly used in the cosmetic or dermatological fields. have. Such adjuvants are introduced in amounts generally used in the cosmetic or dermatological fields.
또한, 상기 화장료 조성물은 제형이 특별히 한정되지 않으며, 목적하는 바에 따라 제형을 적절히 선택할 수 있다.  예를 들어, 유연 화장수, 수렴 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 아이 에센스, 클렌징크림, 클렌징 로션, 클렌징 폼, 클렌징 워터, 팩, 파우더, 콘실 스틱, 바디 로션, 바디 크림, 바디 오일, 바디 에센스, 바디 세정제, 염모제, 헤어 토닉, 모발 영양 화장수, 헤어 에센스, 헤어 세럼, 스칼프 트리트먼트, 헤어 트리트먼트, 헤어 컨디셔너, 헤어 샴푸, 헤어 로션, 치약, 구강 청정제, 정발제, 양모제, 로션, 연고, 젤, 크림, 패치 및 분무제로 이루어진 군으로부터 선택된 하나 이상의 제형으로 제조될 수 있으나, 이에 제한되는 것은 아니다.In addition, the cosmetic composition is not particularly limited in the formulation, it is possible to appropriately select the formulation as desired. For example, flexible lotion, astringent lotion, nourishing lotion, nourishing cream, massage cream, essence, eye cream, eye essence, cleansing cream, cleansing lotion, cleansing foam, cleansing water, pack, powder, conceal stick, body lotion, body Creams, body oils, body essences, body cleansers, hair dyes, hair tonics, hair nourishing lotions, hair essences, hair serums, scalp treatments, hair treatments, hair conditioners, hair shampoos, hair lotions, toothpastes, mouthwashes, hair conditioners , Wool, lotions, ointments, gels, creams, patches, and sprays may be prepared in one or more formulations selected from the group consisting of, but not limited to.
특히, 상기 화장료 조성물은 마이크로 니들 패취를 통하여 피부 장벽을 투과하여 진피층에 영향을 미칠 수 있다. 상기 마이크로 니들은 국부적이면서 지속적인 유효성분 주입이 가능하고, 피부에 삽입 시 통증을 최소화할 수가 있다. 상기 화장료 조성물은 생체적합성이 우수한 생분해성 고분자와 혼합되어 마이크로 니들 패취에 탑재될 수 있으며, 혼합된 점성 용액이 건조되면 고형 상태가 되고, 체내 주입 시 체액에 의하여 다시 용해되는 원리를 이용할 수 있다. 상기 생분해성 고분자로는 히알루론산(Hyaluronic acid) 등이 사용될 수 있으나, 이에 제한되지 않는다. 또한 마이크로 니들 패취에 탑재되는 화장료 조성물 내 유효 성분 농도는 0.01 ~ 5.0 μg/㎖ 일 수 있으며, 보다 바람직하게는 0.1 ~ 3.0 μg/㎖, 가장 바람직하게는 0.1 ~ 2.0 μg/㎖ 일 수 있다. In particular, the cosmetic composition may affect the dermal layer by penetrating the skin barrier through the microneedle patch. The microneedles can be locally and continuously injected with active ingredients and can minimize pain when inserted into the skin. The cosmetic composition may be mixed with a biodegradable polymer having excellent biocompatibility and mounted on a microneedle patch. When the mixed viscous solution is dried, the cosmetic composition may be in a solid state and may be re-dissolved by body fluid when injected into the body. As the biodegradable polymer, hyaluronic acid may be used, but is not limited thereto. In addition, the active ingredient concentration in the cosmetic composition mounted on the microneedle patch may be 0.01 ~ 5.0 μg / ㎖, more preferably 0.1 ~ 3.0 μg / ㎖, most preferably 0.1 ~ 2.0 μg / ㎖.
이하 실시예를 통해 본 발명을 상세히 설명한다. 그러나 이는 발명의 이해를 돕기 위한 것일 뿐, 본 발명이 이에 한정되는 것으로 여겨져서는 안 된다. The present invention will be described in detail through the following examples. However, this is only to aid the understanding of the invention, the present invention should not be considered to be limited thereto.
실시예Example
[봉독 추출물의 제조][Preparation of Bee Venom Extract]
미정제 생봉독 분말 50g을 비이커에 넣고 에틸아세테이트(Ethyl acetate; EA) 400㎖를 가하여 교반기로 20분간 섞어주었다. 교반시킨 봉독을 10분간 초음파(40KHz, 4.5A) 처리하고, 에틸아세테이트로 녹인 용액을 포어 지름이 1 ㎛의 거름종이로 여과하였다. 상기 여과에 의하여 여액의 지용성 추출물을 분리하였고, 걸러진 거름종이 위 잔사는 후드(23℃)에서 20시간 방치하여 용매를 건조시켰다. 상기 건조된 잔사에 증류수 400㎖를 가하여 20분간 교반한 후 10분간 초음파처리 하여 용해시켰다. 이 용액을 위와 같은 포어 지름 1 ㎛의 거름종이로 여과하여 여액의 수용성 추출물을 분리하였다. 50 g of crude raw bee venom powder was added to a beaker, and 400 ml of ethyl acetate (EA) was added thereto, followed by mixing for 20 minutes with a stirrer. The stirred bee venom was treated with ultrasonic waves (40 KHz, 4.5 A) for 10 minutes, and the solution dissolved in ethyl acetate was filtered through a filter paper having a pore diameter of 1 μm. The fat-soluble extract of the filtrate was separated by the filtration, and the residue on the filtered filter paper was left in a hood (23 ° C.) for 20 hours to dry the solvent. 400 ml of distilled water was added to the dried residue, followed by stirring for 20 minutes to dissolve by sonication for 10 minutes. This solution was filtered through a filter paper with a pore diameter of 1 μm as above to separate the aqueous extract of the filtrate.
상기 지용성 추출물과 수용성 추출물을 각각 건조하고 1 : 2의 중량비로 혼합하여 봉독 추출물을 제조하였다. The fat-soluble extract and the water-soluble extract were dried and mixed in a weight ratio of 1: 2 to prepare bee venom extract.
[어성초 추출물의 제조][Preparation of Echo Extract]
건조된 어성초 200g에 중량의 20배인 99.9% 에탄올(Ethanol) 4L를 가하고, 상온에서 30분간 초음파 처리한 후 30분간 방치하는 과정을 10회에 거쳐 반복 추출하여 얻어진 용액을 농축하고 건조하여 어성초 추출물을 제조하였다. 4L of 99.9% ethanol (Ethanol), which is 20 times the weight, is added to 200 g of dried edible vinegar, and the solution obtained by repeatedly extracting the solution obtained by sonication at room temperature for 30 minutes and then left for 30 minutes is concentrated and dried. Prepared.
[화장료 조성물의 제조 및 성분 분석][Production of Cosmetic Composition and Component Analysis]
상기 봉독 추출물과 어성초 추출물을 용매에 넣고 1 : 2의 중량비로 혼합하여 화장료 조성물을 얻었으며, 상기 화장료 조성물의 성분 분석 결과를 하기 표 1에 나타내었다. The bee venom extract and Eochocho extract were put in a solvent and mixed at a weight ratio of 1: 2 to obtain a cosmetic composition, and the results of component analysis of the cosmetic composition are shown in Table 1 below.
성분명 Ingredient Name 중량비(%)Weight ratio (%)
melittinmelittin 27.04 ±1.2027.04 ± 1.20
eicosanoleicosanol 9.42 ± 0.849.42 ± 0.84
PLA2PLA2 9.23 ± 5.239.23 ± 5.23
ApaminApamin 1.01 ± 0.981.01 ± 0.98
PinocembrinPinocembrin 0.04 ± 0.150.04 ± 0.15
ChrysinChrysin 0.04 ± 0.130.04 ± 0.13
QuercitrinQuercitrin 4.36 ± 0.484.36 ± 0.48
QuercetinQuercetin 0.06 ± 0.0260.06 ± 0.026
실험예 1 : 프로콜라겐 합성 및 콜라겐 억제효소 MMP-1 발현 억제 효과Experimental Example 1 Procollagen Synthesis and Collagen Inhibitor MMP-1 Expression Inhibitory Effect
섬유아세포(NHDF)에 상기 실시예의 봉독 추출물 및 화장료 조성물을 전 처리 한 뒤 UV-B(30mJ/cm2)에 노출시키고 24시간 배양한 후 mRNA를 분리하여 RT-PCR 방법으로 프로콜라겐-I 유전자 및 MMP-1 유전자의 발현수준을 확인하였다(도 2).After pretreatment with bee venom extract and cosmetic composition of the above Example to fibroblasts (NHDF) and exposed to UV-B (30mJ / cm 2 ) and incubated for 24 hours, mRNA was isolated by RT-PCR method to procollagen-I gene And the expression level of the MMP-1 gene was confirmed (Fig. 2).
도 2에서 M3는 실시예의 봉독 추출물을 0.083 μg/㎖의 농도로 처리한 결과를 나타낸 것이며, M4는 실시예의 봉독 추출물과 어성초 추출물이 각각 0.083 μg/㎖ 및 0.167 μg/㎖의 농도로 혼합된 화장료 조성물을 처리한 결과이다. In FIG. 2, M3 shows the result of treatment of the bee venom extract of Example at a concentration of 0.083 μg / ml, and M4 is a cosmetic product in which the bee venom extract and Echochocho extract of the example were mixed at concentrations of 0.083 μg / ml and 0.167 μg / ml, respectively. It is the result of processing a composition.
상기 도 2에서 보는 바와 같이, UV-B에 의하여 섬유아세포의 콜라겐 합성을 억제하면서도, MMP-1 발현을 현저히 증가시키는 것을 확인할 수 있다. 본 발명의 봉독 추출물과 어성초 추출물이 일정 농도로 혼합된 화장료 조성물의 경우 봉독 추출물에 비하여 콜라겐 대사의 활성을 현저히 증가시키고, UV-B에 의한 MMP-1 발현을 억제시킴을 확인할 수 있었다. As shown in FIG. 2, while inhibiting collagen synthesis of fibroblasts by UV-B, MMP-1 expression was significantly increased. When the bee venom extract and Eochocho extract of the present invention were mixed at a certain concentration, the cosmetic composition significantly increased the activity of collagen metabolism and suppressed MMP-1 expression by UV-B.
또한, ECM(extracellular matrix) 개선 효과를 가지는 주름개선물질로 알려져 있는 양성대조군 Adenosine과 비교 실험을 진행한 결과를 하기 도 3에 나타내었으며, 양성대조군에 비하여 월등하게 UV-B에 의한 MMP-1 발현을 억제할 수 있음을 확인할 수 있다. In addition, the results of the comparative experiment with the positive control group Adenosine known as wrinkle improvement material having an ECM (extracellular matrix) improvement effect is shown in Figure 3, MMP-1 expression by UV-B is superior to the positive control group It can be confirmed that can be suppressed.
또한, Pro-collagen/MMP-1 ratio를 계산하여 이를 도 4에 나타내었으며, 상기 도 4에서 보는 바와 같이, 봉독 추출물 자체는 양성대조군 Adenosine 처리(10μM, 100μM)한 수준에 못 미치는 결과를 나타내나, 본 발명의 화장료 조성물은 양성대조군에 비하여 월등한 수치를 나타내는 바, 콜라겐 대사 활성이 현저하게 증가하였음을 확인할 수 있었다. In addition, the Pro-collagen / MMP-1 ratio was calculated and shown in FIG. 4, and as shown in FIG. 4, the bee venom extract itself showed less than the result of the positive control Adenosine treatment (10 μM, 100 μM). , The cosmetic composition of the present invention showed an excellent value compared to the positive control group, it was confirmed that the collagen metabolism activity was significantly increased.
따라서 본 발명의 조성물이 UV-B 조사에 의해 일어나는 스트레스에 노출되어 있을 때 ECM의 대사를 조절하는 보호 효과를 가질 뿐 아니라 새로운 콜라겐의 합성을 유도하는 회춘 효과(rejuvenation effect)가 우수함을 알 수 있다. Therefore, it can be seen that the composition of the present invention not only has a protective effect of regulating the metabolism of ECM when exposed to stress caused by UV-B irradiation, but also has an excellent rejuvenation effect that induces the synthesis of new collagen. .
실험예 2 : 항노화 성분과의 효과 비교 Experimental Example 2 Comparison of Effects with Anti-Aging Components
타 항노화 성분과의 효과 비교를 위하여, 주름개선 항노화 기능성 물질인 EGF(Epidermal Growth Factor)와 MMP-1 저해물질로 알려진 녹차의 항노화 유효성분인 EGCG [(-)-Epigallocatechin-3-O- gallate]와의 비교 실험을 진행하였다. EGCG [(-)-Epigallocatechin-3-O, an anti-aging active ingredient of green tea, known as an anti-aging functional substance, EGF (Epidermal Growth Factor) and MMP-1 inhibitor, to compare the effects with other anti-aging ingredients -gallate].
이를 위하여 EGF 10ppm (10μg/㎖), EGCG 0.5uM (0.23μg/㎖)과 상기 M4 조성물을 사용하여 실험예 1과 동일한 실험을 진행하였으며, 그 결과를 도 5에 나타내었다. For this purpose, EGF 10ppm (10μg / ㎖), EGCG 0.5uM (0.23μg / ㎖) using the M4 composition and the same experiment as in Experiment 1, the results are shown in FIG.
상기 도 5에서 보는 바와 같이, 본 발명의 M4 조성물이 EGF나 EGCG에 비하여 항노화 효과가 우수함을 확인할 수 있다. As shown in FIG. 5, the M4 composition of the present invention can be confirmed that the anti-aging effect is superior to EGF or EGCG.
실험예 3 : 봉독 추출물과 어성초 추출물의 농도별 효과 비교Experimental Example 3 Comparison of Effects of Concentrations of Bee Venom Extract and Estuary
각 추출물의 혼합 비율 별 효과를 비교하기 위하여 하기 표 2와 같이 봉독 추출물과 어성초 추출물의 농도를 달리한 조성물을 처리하였으며, 그 결과를 도 6에 나타내었다.In order to compare the effect of each extract by mixing ratio, the composition was treated with different concentrations of bee venom extract and Echochocho extract as shown in Table 2, and the results are shown in FIG.
NoNo 봉독 추출물(μg/㎖)Bee Venom Extract (μg / mL) 어성초 추출물(μg/㎖)Eochocho extract (μg / mL)
1One 0.0420.042 0.1670.167
22 0.0420.042 0.3340.334
33 0.0830.083 0.1670.167
44 0.0830.083 0.3340.334
55 0.1670.167 0.1670.167
66 0.1670.167 0.3340.334
상기 도 6에서 보는 바와 같이 Pro-collagen/MMP-1 ratio를 고려할 때 No.3 시료가 가장 높은 ECM 대사 활성화를 나타낸 바, 봉독 추출물과 어성초 추출물의 중량비가 약 1 : 2로 혼합될 때 우수한 효과를 나타냄을 확인할 수 있었다.  As shown in FIG. 6, when the Pro-collagen / MMP-1 ratio was considered, the No. 3 sample showed the highest ECM metabolic activation, and an excellent effect when the weight ratio of bee venom extract and Echo extract was about 1: 2. It could be confirmed that indicates.
실험예 4 : 마이크로 니들 패취에 의한 투여 효과 Experimental Example 4 Administration Effect by Microneedle Patch
본 발명의 조성물이 피부장벽을 투과하여 진피층에 영향을 미칠 수 있도록 마이크로니들 패취(microneedle patch)를 제작하였으며, 그 과정은 다음과 같다. The microneedle patch was manufactured so that the composition of the present invention penetrates the skin barrier and affects the dermal layer. The procedure is as follows.
먼저, 60% (w/v, 증류수에 용해) 히알루론산 1.92 g, 증류수 3 mL 및 상기 M4 조성물 0.2 mL를 4℃에서 혼합하여, 점성 용액을 제조하였다. First, viscous solution was prepared by mixing 1.92 g of hyaluronic acid, 3 mL of distilled water, and 0.2 mL of the M4 composition at 4 ° C. with 60% (w / v, dissolved in distilled water).
다음, 상기 점성 용액을 금속 기판 일 면에 상기 혼합 용액을 방울(droplet) 형태로 분배한 후, 인장 과정을 통하여 마이크로 니들의 길이를 조절하면서 송풍을 통하여 상온에서 건조하여 마이크로 니들 패치를 제조하였다. 상기 제조 과정은 도 7에 나타내었다. Next, the viscous solution was dispensed in the form of droplets (droplet) of the mixed solution on one surface of the metal substrate, and dried at room temperature through air blowing while adjusting the length of the microneedle through the tensile process to prepare a microneedle patch. The manufacturing process is shown in FIG.
화장품 용도로 사용이 가능하도록 마이크로 니들의 최종 길이를 300 μm 내외로 설정하여, 평균 길이 332.79 ±27.80 μm, 평균 상단부 내경 42.01 ±6.04 μm로 제작하였다. 상기 마이크로 니들이 형성된 패취는 폴리우레탄 필름이 부착된 겔 폼(gel foam) 패취를 사용하였고, 2 cm X 2 cm 의 크기로 제조하였으며, 패취 당 64개의 마이크로 니들이 1 mm 간격으로 탑재되었다. The final length of the microneedle was set to about 300 μm to enable cosmetic use, and an average length of 332.79 ± 27.80 μm and an average top diameter of 42.01 ± 6.04 μm were prepared. The microneedle-shaped patch was used as a gel foam patch (polyurethane film) attached, prepared in a size of 2 cm X 2 cm, 64 micro needles per patch were mounted at 1 mm intervals.
상기 M4 조성물 내 봉독 추출물과 어성초 추출물의 농도 합이 0.16, 0.25, 0.42, 0.50 μg/㎖ 이 되도록 조절하여 마이크로 니들을 제조하였으며, 이를 이용하여 실험예 1과 동일한 실험을 진행하였으며, 그 결과를 도 8에 나타내었다. The microneedle was manufactured by adjusting the sum of concentrations of bee venom extract and Echochocho extract in the M4 composition to be 0.16, 0.25, 0.42, 0.50 μg / ml, and the same experiment as in Experimental Example 1 was conducted, and the results are illustrated in FIG. 8 is shown.
그 결과 상기 M4 조성물의 농도가 0.25 μg/㎖ 이상의 범위에서 농도 의존적으로 MMP-1 발현을 억제시키는 것을 확인할 수 있었다.As a result, it was confirmed that the concentration of the M4 composition inhibits MMP-1 expression in a concentration-dependent manner in the range of 0.25 μg / ml or more.
이상에서는 본 발명의 실시예를 중심으로 설명하였으나, 이는 예시적인 것에 불과하며, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 기술자라면 이로부터 다양한 변형 및 균등한 타 실시예가 가능하다는 점을 이해할 것이다. 따라서 본 발명의 진정한 기술적 보호범위는 이하에 기재되는 특허청구범위에 의해서 판단되어야 할 것이다.Although the above description has been made with reference to embodiments of the present invention, this is merely exemplary, and a person skilled in the art to which the present invention pertains will understand that various modifications and equivalent other embodiments are possible. . Therefore, the true technical protection scope of the present invention will be determined by the claims described below.

Claims (10)

  1. 지용성 용매에 의하여 추출된 봉독의 지용성 추출물과 수용성 용매에 의하여 추출된 봉독의 수용성 추출물이 혼합된 봉독 추출물 100 중량부에 대하여, Based on 100 parts by weight of bee venom extract in which fat soluble extract of bee venom extracted by fat soluble solvent and water soluble extract of bee venom extracted by water soluble solvent are mixed,
    어성초 추출물 50 내지 500 중량부가 포함되는 것을 특징으로 하는 화장료 조성물. Cosmetic composition comprising 50 to 500 parts by weight of Eoseongcho extract.
  2. 제1항에 있어서, The method of claim 1,
    상기 지용성 추출물과 수용성 추출물은 1 : 0.1 ~ 10 의 중량비로 혼합되는 것을 특징으로 하는 화장료 조성물. The fat-soluble extract and the water-soluble extract is a cosmetic composition, characterized in that mixed in a weight ratio of 1: 0.1 to 10.
  3. 제1항에 있어서, The method of claim 1,
    상기 지용성 용매는 헥산, 에테르, 글리세롤, 프로필렌글리콜, 부틸렌글리콜, 에틸아세테이트, 메틸아세테이트, 디클로로메탄 및 클로로포름 중에서 선택되는 1종 또는 2종 이상의 혼합 용매인 것을 특징으로 하는 화장료 조성물. The fat-soluble solvent is a cosmetic composition, characterized in that one or two or more mixed solvents selected from hexane, ether, glycerol, propylene glycol, butylene glycol, ethyl acetate, methyl acetate, dichloromethane and chloroform.
  4. 제1항에 있어서,The method of claim 1,
    상기 수용성 용매는 물 및 C1 ~ C4의 알코올 중에서 선택되는 1종 또는 2종 이상의 혼합 용매인 것을 특징으로 하는 화장료 조성물. The water-soluble solvent is a cosmetic composition, characterized in that one or two or more mixed solvents selected from water and C 1 ~ C 4 alcohol.
  5. 제1항에 있어서,The method of claim 1,
    상기 어성초 추출물은 물 및 C1 ~ C4의 알코올 중에서 선택되는 1종 또는 2종 이상의 혼합 용매에 의하여 추출된 것을 특징으로 하는 화장료 조성물. The Echo extract is a cosmetic composition, characterized in that extracted with one or two or more mixed solvents selected from water and C 1 ~ C 4 alcohol.
  6. 제1항에 있어서,The method of claim 1,
    상기 화장료 조성물은 멜리틴 5 ~ 40 중량%, 에이코세놀(eicosenol) 1 ~ 20 중량%, 포스포리파제A-2 1 ~ 20 중량%, 아파민(Apamin) 0.1 ~ 5 중량%, 피노셈브린(pinocembrin) 0.01 ~ 5 중량% 및 크리신(chrysin) 0.01 ~ 5 중량%를 포함하는 것을 특징으로 하는 화장료 조성물. The cosmetic composition is 5 to 40% by weight melittin, 1 to 20% by weight of eicosenol, phospholipase A-2 1 to 20% by weight, 0.1 to 5% by weight of apamin (Apamin), pinosembrine ( pinocembrin) 0.01 to 5% by weight and chrysin (chrysin) cosmetic composition comprising a 0.01 to 5% by weight.
  7. 제1항에 있어서,The method of claim 1,
    상기 화장료 조성물은 쿼시트린 1 ~ 10 중량% 및 쿼세틴 0.01 ~ 5 중량%를 포함하는 것을 특징으로 하는 화장료 조성물. The cosmetic composition is a cosmetic composition comprising 1 to 10% by weight of quercitrin and 0.01 to 5% by weight of quercetin.
  8. 봉독을 지용성 용매에 넣고 여과하여 여액의 지용성 추출물을 얻는 단계; Putting bee venom in a fat soluble solvent and filtering to obtain a fat soluble extract of the filtrate;
    상기 여과에 의하여 걸러진 잔사를 수용성 용매에 넣고 여과하여 여액의 수용성 추출물을 얻는 단계; Putting the residue filtered by the filtration into a water-soluble solvent to obtain a water-soluble extract of the filtrate;
    상기 지용성 추출물과 수용성 추출물을 혼합하여 봉독 추출물을 제조하는 단계; 및 Preparing a bee venom extract by mixing the fat-soluble extract and a water-soluble extract; And
    상기 봉독 추출물 100 중량부에 대하여 어성초 추출물 50 내지 500 중량부를 혼합하는 단계를 포함하는 것을 특징으로 하는 화장료 조성물의 제조 방법.Method for producing a cosmetic composition comprising the step of mixing 50 to 500 parts by weight of Eoseongcho extract based on 100 parts by weight of the bee venom extract.
  9. 제8항에 있어서, The method of claim 8,
    상기 지용성 추출물과 수용성 추출물을 1 : 0.1 ~ 10 의 중량비로 혼합하여 봉독 추출물을 제조하는 것을 특징으로 하는 화장료 조성물의 제조 방법. Method for producing a cosmetic composition, characterized in that to prepare a bee venom extract by mixing the fat-soluble extract and water-soluble extract in a weight ratio of 1: 0.1 to 10.
  10. 제1항 내지 제7항 중 선택된 어느 한 항의 화장료 조성물을 포함하는 것을 특징으로 하는 마이크로 니들 패취. A microneedle patch comprising the cosmetic composition of any one of claims 1 to 7.
PCT/KR2016/004144 2015-04-24 2016-04-21 Cosmetic composition including apitoxin extract, and method of manufacturing same WO2016171482A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150057894 2015-04-24
KR10-2015-0057894 2015-04-24

Publications (1)

Publication Number Publication Date
WO2016171482A1 true WO2016171482A1 (en) 2016-10-27

Family

ID=57144631

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/004144 WO2016171482A1 (en) 2015-04-24 2016-04-21 Cosmetic composition including apitoxin extract, and method of manufacturing same

Country Status (2)

Country Link
KR (1) KR101841344B1 (en)
WO (1) WO2016171482A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102120146B1 (en) * 2018-10-31 2020-06-08 주식회사 리앤투네이쳐 Cosmetic composition with antioxidative and skin heat dreasing effect
CA3221157A1 (en) * 2021-06-04 2022-12-08 Seon Ju Lee Anti-aging cosmetic composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101061257B1 (en) * 2009-01-30 2011-09-01 주식회사 청진바이오텍 Natural antibiotics using bee venom and herbal extracts as an active ingredient and preparation method thereof
KR20130108826A (en) * 2012-03-26 2013-10-07 대한민국(농촌진흥청장) Cosmetic composition for inhibiting aging
KR101425018B1 (en) * 2012-11-26 2014-08-01 (주)비센 Cosmetic composition for anti-aging comprising lipid soluble fraction of bee venom and method for manufacturing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5408592B2 (en) * 2010-03-19 2014-02-05 コスメディ製薬株式会社 Rapid dissolution method of microneedles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101061257B1 (en) * 2009-01-30 2011-09-01 주식회사 청진바이오텍 Natural antibiotics using bee venom and herbal extracts as an active ingredient and preparation method thereof
KR20130108826A (en) * 2012-03-26 2013-10-07 대한민국(농촌진흥청장) Cosmetic composition for inhibiting aging
KR101425018B1 (en) * 2012-11-26 2014-08-01 (주)비센 Cosmetic composition for anti-aging comprising lipid soluble fraction of bee venom and method for manufacturing the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Moisturizing Cream for Acne and Oily Skin/Bee Venom Moisturizing Cream/ Bee Venom Effect/Heartleaf Houttuynia Moisturizing Cream", WEBSITE: BODEULI'S BLOG, 29 August 2013 (2013-08-29), Retrieved from the Internet <URL:http://blog.naver.com/goldfill2688/70174702745> *

Also Published As

Publication number Publication date
KR20160126896A (en) 2016-11-02
KR101841344B1 (en) 2018-03-26

Similar Documents

Publication Publication Date Title
US5476651A (en) Cosmetic or pharmaceutical composition, especially dermatological composition, intended for promoting the pigmentation of the skin or hair, containing an extract of cyperus, and the process for its manufacture
KR102257524B1 (en) Cosmetic composition for improving skin condition Centella Asiatica―derived exsome having skin calming and regeneration
WO2011122869A2 (en) Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care
KR20110073570A (en) Process for extracting cardiac glycodides and compositions
KR102171133B1 (en) Skin external composition comprising centella asiatica extract and papaver rhoeas extract
WO2012002730A2 (en) Skin-whitening and skin-moisturizing composition containing bee venom extracts
WO2018174453A1 (en) Composition containing cirsium japonicum extract as active ingredient for stimulating melanogenesis
KR20130088912A (en) Skin external composition containing tangeretin and egcg
WO2013089449A1 (en) Cosmetic composition containing the slime of snails fed with red ginseng and method for manufacturing same
JP2001163794A (en) Promoter for production of hyaluronic acid and preparation for external use for skin
CA2517371C (en) Method for the production of flavonoid-containing compositions and their use
WO2018203668A1 (en) External-use skin preparation composition for alleviating atopic skin, and cosmetic containing same
WO2016171482A1 (en) Cosmetic composition including apitoxin extract, and method of manufacturing same
JP3900388B2 (en) Whitening agent and whitening cosmetic
KR101477959B1 (en) Anti-irritating cosmetic compositions for skin comprising extracts of Aloe Aborescens
KR102214985B1 (en) Compositions for improving skin conditions comprising plant extracts or fractions thereof
WO2018111042A2 (en) Cosmetic composition comprising extract of medicinal herbs as active ingredient
KR20210018388A (en) Compositions for improving skin conditions comprising plant extracts or fractions thereof
KR101419588B1 (en) Composition for Moisturizing Skin Comprising Ginseng Oil as Active Ingredient
KR100754748B1 (en) Compositiion for Inhibiting 5?-Reductase Activity and Cosmetic Composition for Inhibiting Secretion of Sebum containing Extract of Ulmus davidiana as Active Ingredient
US5505934A (en) Cosmetic or pharmaceutical composition containing an extract of coleus esquirolii, coleus scutellarioides or coleus xanthanthus
KR100530843B1 (en) Anti-inflammatory composition containing paecilomyces extract and cordyceps extracts as effective composition
WO2012102456A1 (en) Cosmetic composition for reducing wrinkles containing euphorbia supina extracts
KR20090130066A (en) Use of vernonia appendiculata extract for improving the skin status
KR101802355B1 (en) Composition for regenerating skin tissue comprising extract of citrus preicarp

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16783415

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 22/02/2018)

122 Ep: pct application non-entry in european phase

Ref document number: 16783415

Country of ref document: EP

Kind code of ref document: A1